High Throughput AptaMatrix focuses on accelerating aptamer discovery using the High Throughput Screening of Aptamers HTSA approach, presenting an opportunity to partner on large-scale aptamer discovery programs for biotech, pharma, and academic clients seeking rapid candidate identification.

AlloSwitch Platform AlloSwitch sensor technology enables rapid diagnostic tools and drug discovery applications with real-time optical signals, creating potential sales leads in environmental monitoring, public health diagnostics, and security-related contaminant detection contracts.

Genomics Capability In-house genomics division with Illumina platforms and bioinformatics support offers services and collaboration opportunities for sequencing projects, enabling cross-sell to customers needing turnkey sequencing and data analysis from discovery to validation.

Early Stage Client Target Small private company profile with modest revenue but active R&D posture signals potential for strategic partnerships, grants, and co-development deals with larger biotech firms seeking innovative licensing or co-innovation paths.

Strategic Partnerships Existing academic and industry collaborations at Syracuse University point to a readiness for joint ventures and sponsored research, providing a channel to accelerate sales through consortium bids, contract research, and technology licensing discussions.